Abstract:Background: Dispensed prescription medicine labels (prescription labels) are important information sources supporting safe and appropriate medicines use. Objective: To develop and user test patient-centred prescription label formats. Methods: Five stages: developing 12 labels for four fictitious medicines of varying dosage forms; diagnostic user testing of labels (Round 1) with 40 consumers (each testing three labels); iterative label revision, and development of Round 2 labels (n = 7); user testing of labels (Round 2) with 20 consumers (each testing four labels); labelling recommendations. Evaluated labels stated the active ingredient and brand name, using various design features (eg upper case and bold). Dosing was expressed differently across labels: frequency of doses/day, approximate times of day (eg morning), explicit times (eg 7 to 9 AM), and/or explicit dosing interval. Participants' ability to find and understand medicines information and plan a dosing schedule were assessed. Results: Participants demonstrated satisfactory ability to find and understand the dosage for all label formats. Excluding active ingredient and dosing schedule, 14/19 labels (8/12 in Round 1; 6/7 in Round 2) met industry standard on performance. Participants' ability to correctly identify the active ingredient varied, with clear medicine name sign-posting enabling all participants evaluating these labels to find and understand the active ingredient. When planning a dosing schedule, doses were correctly spaced if the label stated a dosing interval, or frequency of doses/day. Two-thirds planned appropriate dosing schedules using a dosing table. Conclusions: Effective prescription label formatting and sign-posting of active ingredient improved communication of information on labels, potentially supporting safe medicines use. Patient and public involvement: Consumers actively contributed to the development of dispensed prescription medicine labels. Feedback from consumers following the first round was incorporated in revisions of the labels for the next round. Patient and public involvement in this study was critical to the development of readable and understandable dispensed prescription medicine labels.

Visual differentiation and recognition memory of look-alike drug names: effects of disfluent format, text enhancement and exposure time

Examining Text Enhancement Methods to Improve Look-alike Drug Name Differentiation Accuracy

Effects of Text Enhancement, Identical Prescription-Package Names, Visual Cues, and Verbal Provocation on Visual Searches of Look-Alike Drug Names: A Simulation and Eye-Tracking Study

Effects of Text Enhancement on Reduction of Look-Alike Drug Name Confusion: A Systematic Review and Meta-analysis

Using name overlap analysis to understand medication name search safety

Assessing the Expectations Associated with Pharmaceutical Pill Colour and Shape

Improving the Accessibility and Legibility of Prescription Medicine Labels for the Elderly in China: A Study on Enhanced Design and Usability Testing

The multisensory design of pharmaceuticals and their packaging

Descriptive analysis of primary package labels from commercially available prescription solid oral dosage form drugs

Transfer of Repeated Exposure Cost Via Color–flavor Associations

Color memory and evaluations for alphabetic and logographic brand names

A Survey of Patients' Perceptions of Pill Appearance and Responses to Changes in Appearance for Four Chronic Disease Medications

Effects of Scopolamine on Delayed-Matching-To-Sample and Paired Associates Tests of Visual Memory and Learning in Human Subjects: Comparison with Diazepam and Implications for Dementia

Evaluation of the design and structure of electronic medication labels to improve patient health knowledge and safety: a systematic review

Developing and user testing new pharmacy label formats-A study to inform labelling standards

Consumer confusion between prescription drug precautions and side effects

Dissociating the Effects of Visual Similarity for Brand Names and Common Words

Visual images of prescription drug benefits in direct-to-consumer television advertisements

Increasing the salience of fluency cues does not reduce the recognition memory impairment in Alzheimer's disease!

Scoring System of Alike Drugs Evaluation in Children's Inpatient Pharmacy

Sequential perceptual learning of letter identification and "uncrowding" in normal peripheral vision: Effects of task, training order, and cholinergic enhancement